Physician profile
Claudio A Levin
NPI 1356398051
$2,103.92
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,310 · 2020: $557 · 2021: $16.56 · 2022: $204 · 2023: $15.94.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $15.94.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $15.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $241.83 | 2019-2020 | |
| Novo Nordisk INC | $235.89 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $203.53 | 2019-2022 | |
| Amarin Pharma, INC. | $197.82 | 2019-2020 | |
| Pfizer INC. | $182.28 | 2019-2020 | |
| Amgen INC. | $182.22 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $119.19 | 2019-2020 | |
| Lilly USA, LLC | $94.60 | 2019-2020 | |
| Abbvie INC. | $90.28 | 2022 | |
| Astellas Pharma US INC | $86.46 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $83.01 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $63.35 | 2019-2020 | |
| Allergan, INC. | $56.87 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $48.40 | 2019-2020 | |
| Hikma Pharmaceuticals USA | $34.66 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $34.01 | 2019 | |
| Novartis Pharmaceuticals Corporation | $32.12 | 2022-2023 | |
| Daiichi Sankyo INC. | $28.25 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $23.43 | 2019 | |
| Alnylam Pharmaceuticals INC. | $20.27 | 2019 | |
| Sanofi Pasteur INC. | $17.84 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.67 | 2022 | |
| Abbott Laboratories | $10.94 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Claudio Levin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.